Samia Mora, MD, MHS

All posts by Samia Mora, MD, MHS

September 23rd, 2013

HDL-P: The Better Marker of Residual Risk?

CardioExchange Editors interview Samia Mora about her investigative group’s analysis of data from the JUPITER trial, which reveals that HDL-P may be a better marker of residual risk than chemically measured HDL-C or apoA-1.